411 related articles for article (PubMed ID: 30134924)
21. Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis.
Gentile A; Musella A; Bullitta S; Fresegna D; De Vito F; Fantozzi R; Piras E; Gargano F; Borsellino G; Battistini L; Schubart A; Mandolesi G; Centonze D
J Neuroinflammation; 2016 Aug; 13(1):207. PubMed ID: 27566665
[TBL] [Abstract][Full Text] [Related]
22. Tellurium compound AS101 ameliorates experimental autoimmune encephalomyelitis by VLA-4 inhibition and suppression of monocyte and T cell infiltration into the CNS.
Lee JH; Halperin-Sheinfeld M; Baatar D; Mughal MR; Tae HJ; Kim JW; Carter A; Lustig A; Snir O; Lavie G; Okun E; Mattson MP; Sredni B; Taub DD
Neuromolecular Med; 2014 Jun; 16(2):292-307. PubMed ID: 24272426
[TBL] [Abstract][Full Text] [Related]
23. Discordant effects of anti-VLA-4 treatment before and after onset of relapsing experimental autoimmune encephalomyelitis.
Theien BE; Vanderlugt CL; Eagar TN; Nickerson-Nutter C; Nazareno R; Kuchroo VK; Miller SD
J Clin Invest; 2001 Apr; 107(8):995-1006. PubMed ID: 11306603
[TBL] [Abstract][Full Text] [Related]
24. The inhibition of Rho kinase blocks cell migration and accumulation possibly by challenging inflammatory cytokines and chemokines on astrocytes.
Guo MF; Meng J; Li YH; Yu JZ; Liu CY; Feng L; Yang WF; Li JL; Feng QJ; Xiao BG; Ma CG
J Neurol Sci; 2014 Aug; 343(1-2):69-75. PubMed ID: 24952673
[TBL] [Abstract][Full Text] [Related]
25. Keratan sulfate exacerbates experimental autoimmune encephalomyelitis.
Ueno R; Miyamoto K; Tanaka N; Moriguchi K; Kadomatsu K; Kusunoki S
J Neurosci Res; 2015 Dec; 93(12):1874-80. PubMed ID: 26340909
[TBL] [Abstract][Full Text] [Related]
26. Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes.
Berghmans N; Heremans H; Li S; Martens E; Matthys P; Sorokin L; Van Damme J; Opdenakker G
J Neuroinflammation; 2012 Oct; 9():243. PubMed ID: 23095573
[TBL] [Abstract][Full Text] [Related]
27. Involvement of the choroid plexus in central nervous system inflammation.
Engelhardt B; Wolburg-Buchholz K; Wolburg H
Microsc Res Tech; 2001 Jan; 52(1):112-29. PubMed ID: 11135454
[TBL] [Abstract][Full Text] [Related]
28. Anti-CD52 antibody treatment depletes B cell aggregates in the central nervous system in a mouse model of multiple sclerosis.
Simon M; Ipek R; Homola GA; Rovituso DM; Schampel A; Kleinschnitz C; Kuerten S
J Neuroinflammation; 2018 Aug; 15(1):225. PubMed ID: 30098594
[TBL] [Abstract][Full Text] [Related]
29. Laminins 411 and 421 differentially promote tumor cell migration via α6β1 integrin and MCAM (CD146).
Ishikawa T; Wondimu Z; Oikawa Y; Gentilcore G; Kiessling R; Egyhazi Brage S; Hansson J; Patarroyo M
Matrix Biol; 2014 Sep; 38():69-83. PubMed ID: 24951930
[TBL] [Abstract][Full Text] [Related]
30. Mapping the accumulation of co-infiltrating CNS dendritic cells and encephalitogenic T cells during EAE.
Clarkson BD; Walker A; Harris M; Rayasam A; Sandor M; Fabry Z
J Neuroimmunol; 2014 Dec; 277(1-2):39-49. PubMed ID: 25288303
[TBL] [Abstract][Full Text] [Related]
31. Artesunate Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibiting Leukocyte Migration to the Central Nervous System.
Thomé R; de Carvalho AC; Alves da Costa T; Ishikawa LL; Fraga-Silva TF; Sartori A; de Oliveira AL; Verinaud L
CNS Neurosci Ther; 2016 Aug; 22(8):707-14. PubMed ID: 27165523
[TBL] [Abstract][Full Text] [Related]
32. Th17 lymphocytes traffic to the central nervous system independently of α4 integrin expression during EAE.
Rothhammer V; Heink S; Petermann F; Srivastava R; Claussen MC; Hemmer B; Korn T
J Exp Med; 2011 Nov; 208(12):2465-76. PubMed ID: 22025301
[TBL] [Abstract][Full Text] [Related]
33. G-CSF treatment promotes apoptosis of autoreactive T cells to restrict the inflammatory cascade and accelerate recovery in experimental allergic encephalomyelitis.
Peng W
Exp Neurol; 2017 Mar; 289():73-84. PubMed ID: 27771353
[TBL] [Abstract][Full Text] [Related]
34. Granzyme B-inhibitor serpina3n induces neuroprotection in vitro and in vivo.
Haile Y; Carmine-Simmen K; Olechowski C; Kerr B; Bleackley RC; Giuliani F
J Neuroinflammation; 2015 Sep; 12():157. PubMed ID: 26337722
[TBL] [Abstract][Full Text] [Related]
35. Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment.
Brocke S; Piercy C; Steinman L; Weissman IL; Veromaa T
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6896-901. PubMed ID: 10359810
[TBL] [Abstract][Full Text] [Related]
36. Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions.
Pifarré P; Gutierrez-Mecinas M; Prado J; Usero L; Roura-Mir C; Giralt M; Hidalgo J; García A
Exp Neurol; 2014 Jan; 251():58-71. PubMed ID: 24211383
[TBL] [Abstract][Full Text] [Related]
37. The roles of adhesion molecules and proteinases in lymphocyte transendothelial migration.
Madri JA; Graesser D; Haas T
Biochem Cell Biol; 1996; 74(6):749-57. PubMed ID: 9164645
[TBL] [Abstract][Full Text] [Related]
38. MCAM/CD146 Signaling
Zondler L; Herich S; Kotte P; Körner K; Schneider-Hohendorf T; Wiendl H; Schwab N; Zarbock A
Front Immunol; 2020; 11():599936. PubMed ID: 33381120
[TBL] [Abstract][Full Text] [Related]
39. Predicting the effects of potentially therapeutic modified peptides on polyclonal T cell populations in a mouse model of multiple sclerosis.
Sauer EL; Trifilieff E; Greer JM
J Neuroimmunol; 2017 Jun; 307():18-26. PubMed ID: 28495132
[TBL] [Abstract][Full Text] [Related]
40. Circulating EZH2-positive T cells are decreased in multiple sclerosis patients.
Malhotra S; Villar LM; Costa C; Midaglia L; Cubedo M; Medina S; Fissolo N; Río J; Castilló J; Álvarez-Cermeño JC; Sánchez A; Montalban X; Comabella M
J Neuroinflammation; 2018 Oct; 15(1):296. PubMed ID: 30367633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
